Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer’s disease, Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy

Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer’s disease, Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy

Abstract Background This study examined the usefulness of cerebrospinal fluid (CSF) neuron-specific enolase (NSE) levels as a candidate biomarker of neurodegeneration in Alzheimer’s disease (AD), Parkinson’s disease (PD), PD with dementia (PDD), dementia with Lewy bodies (DLB), and multiple system a...

Full description

Bibliographic Details
Main Authors: Takayuki Katayama, Jun Sawada, Kae Takahashi, Osamu Yahara, Naoyuki Hasebe
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Alzheimer’s Research & Therapy
Subjects:
Neuron-specific enolase
Cerebrospinal fluid
Alzheimer’s disease
Parkinson’s disease
Dementia with Lewy bodies
Multiple system atrophy
Online Access:https://doi.org/10.1186/s13195-021-00907-3

Internet

https://doi.org/10.1186/s13195-021-00907-3

Similar Items